Cited by 179Neurological Disease Mechanisms and TreatmentsCerebrovascular and genetic disordersBarrier Structure and Function Studies

Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function

Open access
Koizumi, Kenzo, Hattori, Yorito, Ahn, Sung Ji, Buendia, Izaskun, Ciacciarelli, Antonio, Uekawa, Ken, Wang, Gang, Hiller, Abigail +6 more·2018·Nature Communications

Abstract

The ApoE4 allele is associated with increased risk of small vessel disease, which is a cause of vascular cognitive impairment. Here, we report that mice with targeted replacement (TR) of the ApoE gene with human ApoE4 have reduced neocortical cerebral blood flow compared to ApoE3-TR mice, an effect due to reduced vascular density rather than slowing of microvascular red blood cell flow. Furthermore, homeostatic mechanisms matching local delivery of blood flow to brain activity are impaired in ApoE4-TR mice. In a model of cerebral hypoperfusion, these cerebrovascular alterations exacerbate damage to the white matter of the corpus callosum and worsen cognitive dysfunction. Using 3-photon microscopy we found that the increased white matter damage is linked to an enhanced reduction of microvascular flow resulting in local hypoxia. Such alterations may be responsible for the increased susceptibility to hypoxic-ischemic lesions in the subcortical white matter of individuals carrying the ApoE4 allele.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-06301-2

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • APOE4 reduces the density of blood vessels in these mice, thereby potentially impairing oxygen availability to neurons.

    “APOE4 also reduces the density of blood vessels in these mice, thereby potentially impairing oxygen availability to neurons188.”

    From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [188]

  • APOE4 has a negative impact on cerebral blood flow and neurovascular coupling; APOE4 mice show reduced cerebral blood flow both at baseline and in stimulus-evoked paradigms, relative to APOE3 mice.

    “APOE4 has a negative impact on cerebral blood flow and neurovascular coupling; APOE4 mice show reduced cerebral blood flow both at baseline and in stimulus-evoked paradigms, relative to APOE3 mice187–189.”

    From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [188]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 55

  1. [1]Dichgans M Leys D Vascular cognitive impairment Circ. Res. 2017 120 573 591 10.1161/CIRCRESAHA.116.308426 28154105 · DOI · Paper page
  2. [2]Hughes TM Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET Study Neurology 2018 90 e1248 e1256 10.1212/WNL.0000000000005259 29549223 PMC5890613 · DOI
  3. [4]Provenzano FA White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol. 2013 70 455 461 10.1001/jamaneurol.2013.1321 23420027 PMC4124641 · DOI · Paper page
  4. [5]Iadecola C The pathobiology of vascular dementia Neuron 2013 80 844 866 10.1016/j.neuron.2013.10.008 24267647 PMC3842016 · DOI · Paper page
  5. [8]Davidson Y Apolipoprotein E epsilon4 allele frequency in vascular dementia Dement. Geriatr. Cogn. Disord. 2006 22 15 19 10.1159/000092960 16645276 · DOI
  6. [9]Luo X Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study Oncotarget 2017 8 44477 44489 28574812 PMC5546495
  7. [10]Sun JH Genetics of vascular dementia: systematic review and meta-analysis J. Alzheimers Dis. 2015 46 611 629 10.3233/JAD-143102 25835425 · DOI
  8. [11]Schilling S APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis Neurology 2013 81 292 300 10.1212/WNL.0b013e31829bfda4 23858411 PMC3770168 · DOI
  9. [12]Rojas S Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-varepsilon4 allele carriers aged 45-75: results from the ALFA study J. Cereb. Blood. Flow. Metab. 2018 38 250 261 10.1177/0271678X17707397 28492093 PMC5951016 · DOI
  10. [13]Sudre CH APOE epsilon4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis Neurobiol. Aging 2017 53 67 75 10.1016/j.neurobiolaging.2017.01.014 28235680 · DOI
  11. [14]Haller S Cerebral microbleeds: imaging and clinical significance Radiology 2018 287 11 28 10.1148/radiol.2018170803 29558307 · DOI · Paper page
  12. [17]Tai LM The role of APOE in cerebrovascular dysfunction Acta Neuropathol. 2016 131 709 723 10.1007/s00401-016-1547-z 26884068 PMC4837016 · DOI · Paper page
  13. [19]Santisakultarm TP In vivo two-photon excited fluorescence microscopy reveals cardiac- and respiration-dependent pulsatile blood flow in cortical blood vessels in mice Am. J. Physiol. Heart Circ. Physiol. 2012 302 H1367 H1377 10.1152/ajpheart.00417.2011 22268102 PMC3330793 · DOI
  14. [20]Iadecola C The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease Neuron 2017 96 17 42 10.1016/j.neuron.2017.07.030 28957666 PMC5657612 · DOI · Paper page
  15. [21]Lecrux C Pyramidal neurons are “neurogenic hubs” in the neurovascular coupling response to whisker stimulation J. Neurosci. 2011 31 9836 9847 10.1523/JNEUROSCI.4943-10.2011 21734275 PMC6703330 · DOI
  16. [22]Back SA Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes Ann. Neurol. 2005 58 108 120 10.1002/ana.20530 15984031 · DOI
  17. [23]Jofre-Monseny L Differential effects of apolipoprotein E3 and E4 on markers of oxidative status in macrophages Br. J. Nutr. 2007 97 864 871 10.1017/S0007114507669219 17381973 · DOI
  18. [24]Shibata M Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion Stroke 2007 38 2826 2832 10.1161/STROKEAHA.107.490151 17761909 · DOI
  19. [25]Ouzounov DG In vivo three-photon imaging of activity of GCaMP6-labeled neurons deep in intact mouse brain Nat. Methods 2017 14 388 390 10.1038/nmeth.4183 28218900 PMC6441362 · DOI
  20. [26]Hattori Y A novel mouse model of subcortical infarcts with dementia J. Neurosci. 2015 35 3915 3928 10.1523/JNEUROSCI.3970-14.2015 25740520 PMC6605574 · DOI
  21. [27]Arancibia-Carcamo IL Attwell D The node of Ranvier in CNS pathology Acta Neuropathol. 2014 128 161 175 10.1007/s00401-014-1305-z 24913350 PMC4102831 · DOI · Paper page
  22. [28]Suri S Reduced cerebrovascular reactivity in young adults carrying the APOE epsilon4 allele Alzheimer’s Dement. 2015 11 648 657 10.1016/j.jalz.2014.05.1755 25160043 · DOI
  23. [29]Hainsworth AH Translational models for vascular cognitive impairment: a review including larger species BMC Med. 2017 15 16 10.1186/s12916-017-0793-9 28118831 PMC5264492 · DOI
  24. [31]Coltman R Selective white matter pathology induces a specific impairment in spatial working memory Neurobiol. Aging 2011 32 2324 e2327 2312 10.1016/j.neurobiolaging.2010.09.005 20961660 · DOI
  25. [32]Lin AL Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease J. Cereb. Blood. Flow. Metab. 2017 37 217 226 10.1177/0271678X15621575 26721390 PMC5167110 · DOI
  26. [33]Girouard H Park L Anrather J Zhou P Iadecola C Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II Arterioscler. Thromb. Vasc. Biol. 2007 27 303 309 10.1161/01.ATV.0000253885.41509.25 17138940 · DOI
  27. [34]Niwa K Haensel C Ross ME Iadecola C Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation Circ. Res. 2001 88 600 608 10.1161/01.RES.88.6.600 11282894 · DOI
  28. [37]Liu Q., et al. Experimental chronic cerebral hypoperfusion results in decreased pericyte coverage and increased blood-brain barrier permeability in the corpus callosum. J Cereb Blood Flow Metab. 271678X17743670 (2017). PMC6365610 29192539
  29. [39]Petersen MA Ryu JK Akassoglou K Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics Nat. Rev. Neurosci. 2018 19 283 301 10.1038/nrn.2018.13 29618808 PMC6743980 · DOI · Paper page
  30. [40]Brown WR Thore CR Review: cerebral microvascular pathology in ageing and neurodegeneration Neuropathol. Appl. Neurobiol. 2011 37 56 74 10.1111/j.1365-2990.2010.01139.x 20946471 PMC3020267 · DOI · Paper page
  31. [41]Kilkenny C Animal research: reporting in vivo experiments–the ARRIVE guidelines J. Cereb. Blood. Flow. Metab. 2011 31 991 993 10.1038/jcbfm.2010.220 21206507 PMC3070981 · DOI · Paper page
  32. [43]Wang C Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology Neurobiol. Dis. 2005 18 390 398 10.1016/j.nbd.2004.10.013 15686968 · DOI · Paper page
  33. [45]Biffi A APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study Lancet Neurol. 2011 10 702 709 10.1016/S1474-4422(11)70148-X 21741316 PMC3153411 · DOI
  34. [46]Jackman K Progranulin deficiency promotes post-ischemic blood-brain barrier disruption J. Neurosci. 2013 33 19579 19589 10.1523/JNEUROSCI.4318-13.2013 24336722 PMC3858627 · DOI
  35. [47]Paxinos G Franklin KBJ The Mouse Brain in Stereotaxic Coordinates. 2004 London Elsevier Academic Press,
  36. [48]Iadecola C SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein Nat. Neurosci. 1999 2 157 161 10.1038/5715 10195200 · DOI · Paper page
  37. [49]Uekawa K Obligatory role of EP1 receptors in the increase in cerebral blood flow produced by hypercapnia in the mice PLoS One 2016 11 e0163329 10.1371/journal.pone.0163329 27657726 PMC5033465 · DOI
  38. [50]Dunn AK Bolay H Moskowitz MA Boas DA Dynamic imaging of cerebral blood flow using laser speckle J. Cereb. Blood. Flow. Metab. 2001 21 195 201 10.1097/00004647-200103000-00002 11295873 · DOI
  39. [51]Holtmaat A Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window Nat. Protoc. 2009 4 1128 1144 10.1038/nprot.2009.89 19617885 PMC3072839 · DOI
  40. [52]Pologruto TA Sabatini BL Svoboda K ScanImage: flexible software for operating laser scanning microscopes Biomed. Eng. Online 2003 2 13 10.1186/1475-925X-2-13 12801419 PMC161784 · DOI
  41. [53]Dietzel S Label-free determination of hemodynamic parameters in the microcirculaton with third harmonic generation microscopy PLoS One 2014 9 e99615 10.1371/journal.pone.0099615 24933027 PMC4059650 · DOI
  42. [54]Farrar MJ Wise FW Fetcho JR Schaffer CB In vivo imaging of myelin in the vertebrate central nervous system using third harmonic generation microscopy Biophys. J. 2011 100 1362 1371 10.1016/j.bpj.2011.01.031 21354410 PMC3043202 · DOI
  43. [55]Kim TN Line-scanning particle image velocimetry: an optical approach for quantifying a wide range of blood flow speeds in live animals PLoS One 2012 7 e38590 10.1371/journal.pone.0038590 22761686 PMC3383695 · DOI
  44. [56]Li C Trapp B Ludwin S Peterson A Roder J Myelin associated glycoprotein modulates glia-axon contact in vivo J. Neurosci. Res. 1998 51 210 217 10.1002/(SICI)1097-4547(19980115)51:2<210::AID-JNR9>3.0.CO;2-G 9469574 · DOI
  45. [57]Coleman CG Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus J. Neurosci. 2010 30 12103 12112 10.1523/JNEUROSCI.3367-10.2010 20826673 PMC2951676 · DOI
  46. [58]Park L The key role of transient receptor potential melastatin-2 channels in amyloid-beta-induced neurovascular dysfunction Nat. Commun. 2014 5 5318 10.1038/ncomms6318 25351853 PMC4283829 · DOI
  47. [59]Kawano T Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity Nat. Med. 2006 12 225 229 10.1038/nm1362 16432513 · DOI
  48. [60]Park L Innate immunity receptor CD36 promotes cerebral amyloid angiopathy Proc. Natl. Acad. Sci. USA 2013 110 3089 3094 10.1073/pnas.1300021110 23382216 PMC3581946 · DOI
  49. [61]Lee E. S., et al. A mouse model of subcortical vascular dementia reflecting degeneration of cerebral white matter and microcirculation. J Cereb Blood Flow Metab. 271678X17736963 (2017). PMC6311665 29053032
  50. [62]Toyama K Apoptosis signal-regulating kinase 1 is a novel target molecule for cognitive impairment induced by chronic cerebral hypoperfusion Arterioscler. Thromb. Vasc. Biol. 2014 34 616 625 10.1161/ATVBAHA.113.302440 24371084 · DOI
  51. [63]Zuloaga KL High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion J. Cereb. Blood. Flow. Metab. 2016 36 1257 1270 10.1177/0271678X15616400 26661233 PMC4929700 · DOI
  52. [64]Aggleton JP Pearce JM Neural systems underlying episodic memory: insights from animal research Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2001 356 1467 1482 10.1098/rstb.2001.0946 11571037 PMC1088529 · DOI
  53. [65]Dellu F Contarino A Simon H Koob GF Gold LH Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice Neurobiol. Learn. Mem. 2000 73 31 48 10.1006/nlme.1999.3919 10686122 · DOI · Paper page
  54. [66]Vorhees CV Williams MT Assessing spatial learning and memory in rodents Ilar. J. 2014 55 310 332 10.1093/ilar/ilu013 25225309 PMC4240437 · DOI
  55. [67]Wenk GL Assessment of spatial memory using the radial arm maze and Morris water maze Curr. Protoc. Neurosci. 2004 Chapter 8 5A 18428607

Cited by

Sorted by citations

Authors
Koizumi, K., Hattori, Y., Ahn, S. J., Buendia, I., Ciacciarelli, A., Uekawa, K., Wang, G., Hiller, A., Zhao, L., Voss, H. U., Paul, S. M., Schaffer, C., Park, L., & Iadecola, C.
Affiliations
  • Weill Cornell Medicine (US)
  • Washington University in St. Louis (US)
  • Cornell University (US)
Corresponding author
  • Park, Laibaik
  • Iadecola, Costantino
Venue
Nature Communications
Published
2018-09-19
Volume
9
Issue
1
Pages
3816-3816
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2891667574
Cited by
179
References
12
Citations by year
2026: 22 · 2025: 30 · 2024: 25 · 2023: 21 · 2022: 21 · 2021: 21 · 2020: 24 · 2019: 13 · 2018: 1
FWCI
6.63
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (097805, 100447)
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
APOE ε4, apolipoprotein E, cerebral small vessel disease, vascular cognitive impairment, cerebral blood flow, neocortex, cerebral microvasculature, vessel density, white matter injury, corpus callosum, hypoxia, cerebral hypoperfusion, hypoxia-ischemia, cognitive impairment, targeted replacement mice
MeSH terms
Animals, Apolipoproteins E, Cerebrovascular Circulation, Cognition, Corpus Callosum, Humans, Metalloporphyrins, Mice, Inbred C57BL, Mice, Transgenic, Rest, Carotid Stenosis, Gene Targeting, White Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review